Bonus BioGroup
Viable Tissue-regenerating Bone Grafts
StartupBonus BioGroup is a Haifa-based startup in the Health Tech & Life Sciences sector, established in 1981. Viable Tissue-regenerating Bone Grafts. The company has raised a total of $25.6M across 5 funding rounds, currently at the Public stage. Bonus BioGroup was founded by Shai Meretzki and Prof. Avinoam Kadouri (late). Key investors include SIBF VC, Undisclosed Investor(s). The company has 11-50 employees. Core technologies: Biologicals, Cells.
With $25.6M in total funding, Bonus BioGroup is a Public-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Clinical Trial. The company holds 1 patent.
- StagePublic
- ProductClinical Trial
- ModelB2B
- Employees11-50
- HQHaifa
- DistrictNorth District
- Last Round$5M
- SIBF VC
- Undisclosed Investor(s)
Shai MeretzkiFounder, CEO & President
Prof. Avinoam Kadouri (late)Founder (No longer with the company)
38 articles covered by sources including finance.yahoo.com,
www.hotelmanagement-network.com,
sg.finance.yahoo.com,
www.sponser.co.il,
itnews.co.il.
What does Bonus BioGroup do?
Bonus BioGroup is a product-focused biotechnology company applying proprietary technology to supply tissue-regenerating, viable bone grafts. The company develops cell therapy and tissue-engineering products based on autologous bone implants that enable efficient bone transplantation and provide cell-based bone replacement for repairing bone lesions. Bonus BioGroup is the developer of BonoFill, a method for growing high-density 3D bone grafts based on multicell 3D cultures. BonoFill is derived from the patients own cells and constructed from a variety of cells grown in multiple layers within a bioreactor system. BonoFills technology enables the construction of bone grafts outside of the human body (ex vivo) and promotes graft acceptance by the patients body following transplantation. It also allows growth of a human tissue graft tailored to the biological, physical, and clinical needs of each patient, without incurring immune reactions or graft rejection.
How much funding has Bonus BioGroup raised?
Bonus BioGroup has raised $25.6M in total funding across 5 rounds. The company is currently at the Public stage. Key investors include SIBF VC, Undisclosed Investor(s).
Who founded Bonus BioGroup?
Bonus BioGroup was founded in 1981 by Shai Meretzki (Founder, CEO & President), Prof. Avinoam Kadouri (late) (Founder (No longer with the company)).
What sector is Bonus BioGroup in?
Bonus BioGroup operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Biologicals, Cells. Target customers: Healthcare & Life Sciences, Healthcare, Patients, Providers, Life Sciences, Biotechnology.
Where is Bonus BioGroup located?
Bonus BioGroup is based in Nahum Het St 9, Haifa, Israel, North District.